STAT+: Federal regulators invite industry, researchers, and lobbyists to closed-door meetings on clinical AI
Reported by STAT News · all stories from statnews.com
Editorial digest
Government regulators are holding closed-door sessions with industry leaders, researchers, and lobbyists concerning clinical artificial intelligence. These meetings aim to discuss the future of AI in healthcare.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at STAT News →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom9/3/2026
STAT+: FDA pilot offers generative AI medical devices a path to patients before they are authorized
FDA pilot program allows generative AI devices to reach patients pre-authorization.
- Trusted health newsroom9/1/2026
STAT+: FDA clears Stryker’s ‘surgical cockpit’ that uses Apple’s VR headset, Vision Pro
Stryker's system for surgery, using Apple Vision Pro, received FDA clearance.
- Trusted health newsroom8/25/2026
STAT+: FDA promises new AI guidance, and what happened at Epic’s UGM
The FDA will issue new AI regulations; Epic's user meeting also had significant updates.
- Trusted health newsroom8/27/2026
STAT+: CMS plans launch event for ACCESS, the Medicare chronic care pilot
CMS is preparing an event for its new chronic care pilot, ACCESS.
- Trusted health newsroom8/11/2026
STAT+: A RAPID proposal for breakthrough coverage, and nurses push back on AI
A proposal for rapid breakthrough coverage emerges as nurses challenge AI.
- Trusted health newsroom8/26/2026
STAT+: AI biotech Insitro’s Daphne Koller on how to speed up clinical trials
Daphne Koller from Insitro discusses using artificial intelligence to accelerate clinical studies.